Sukru Tuzmen - Publications

Affiliations: 
Eastern Mediterranean University, North Cyprus 

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Mamo A, Cavallone L, Tuzmen S, Chabot C, Ferrario C, Hassan S, Edgren H, Kallioniemi O, Aleynikova O, Przybytkowski E, Malcolm K, Mousses S, Tonin PN, Basik M. An integrated genomic approach identifies ARID1A as a candidate tumor-suppressor gene in breast cancer. Oncogene. 31: 2090-100. PMID 21892209 DOI: 10.1038/Onc.2011.386  0.322
2011 Savas S, Azorsa DO, Jarjanazi H, Ibrahim-Zada I, Gonzales IM, Arora S, Henderson MC, Choi YH, Briollais L, Ozcelik H, Tuzmen S. NCI60 cancer cell line panel data and RNAi analysis help identify EAF2 as a modulator of simvastatin and lovastatin response in HCT-116 cells. Plos One. 6: e18306. PMID 21483694 DOI: 10.1371/Journal.Pone.0018306  0.557
2011 Basak AN, Tuzmen S. Genetic predisposition to β-thalassemia and sickle cell anemia in Turkey: a molecular diagnostic approach. Methods in Molecular Biology (Clifton, N.J.). 700: 291-307. PMID 21204041 DOI: 10.1007/978-1-61737-954-3_19  0.482
2008 Jarjanazi H, Kiefer J, Savas S, Briollais L, Tuzmen S, Pabalan N, Ibrahim-Zada I, Mousses S, Ozcelik H. Discovery of genetic profiles impacting response to chemotherapy: application to gemcitabine. Human Mutation. 29: 461-7. PMID 18330920 DOI: 10.1002/Humu.20732  0.561
2007 Kuuselo R, Savinainen K, Azorsa DO, Basu GD, Karhu R, Tuzmen S, Mousses S, Kallioniemi A. Intersex-like (IXL) is a cell survival regulator in pancreatic cancer with 19q13 amplification. Cancer Research. 67: 1943-9. PMID 17332321 DOI: 10.1158/0008-5472.CAN-06-3387  0.426
2006 Savas S, Tuzmen S, Ozcelik H. Human SNPs resulting in premature stop codons and protein truncation. Human Genomics. 2: 274-86. PMID 16595072 DOI: 10.1186/1479-7364-2-5-274  0.525
2004 Huusko P, Ponciano-Jackson D, Wolf M, Kiefer JA, Azorsa DO, Tuzmen S, Weaver D, Robbins C, Moses T, Allinen M, Hautaniemi S, Chen Y, Elkahloun A, Basik M, Bova GS, et al. Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer. Nature Genetics. 36: 979-83. PMID 15300251 DOI: 10.1038/Ng1408  0.553
Show low-probability matches.